Andrew Lewis

Andrew Lewis serves as the Managing Director of Venture Investments at the Cystic Fibrosis Foundation, where responsibilities include overseeing a substantial venture capital fund with a commitment exceeding $600 million by 2025. In addition to this role, Andrew holds the position of Senior Director of Venture Investments at Vianautis and serves as a Board Observer for multiple organizations including Carbon Biosciences, gensaic, and Splisense. Andrew's extensive experience is further highlighted by involvement in advisory capacities and board memberships across various biotech and healthcare-focused institutions. Educational qualifications include a Master of Business & Science in Biotech Management from Keck Graduate Institute and a Genetics & Genomics Certificate from Stanford University School of Medicine, among others.